Piramal Pharma invests $32M to expand API facility in US
Bio Spectrum|February 2021
Mumbai based Piramal Pharma Limited’s Pharma Solutions business, a leading contract development and manufacturing organization (CDMO), has announced plans to expand its facility in Michigan in the US with additional capacity and new capabilities for the development and manufacturing of Active Pharmaceutical Ingredients (APIs).

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BIO SPECTRUMView All

“We are particularly looking forward to increasing our business in India”

Emerging from the Institute of Cell Culture Technology at Bielefeld University, Germany, in 2009, Xell AG (formerly TeutoCell AG), has grown to become an independent and privately financed biotech company dedicated to cutting-edge innovation and developing expertise. With more than 20 years of hands-on experience in cell culture technology, Xell has drawn from its academic and technological knowledge to become a key partner in the design and distribution of cell culture solutions. The company is currently serving the Indian market through its partnership with Navi Mumbai-based Rane Rao Reshamia Laboratories. BioSpectrum interacted with Prof. Thomas Noll, Chairman, Supervisory Board, Xell AG, Germany to find out more about the company’s plans for 2021 and beyond. Edited excerpts;

5 mins read
Bio Spectrum
April 2021

BioSpectrum honours INDUSTRY STALWARTS

It is time to celebrate the outstanding contribution and achievements of the Indian Bio Sciences industry leaders and organisations over the past one year.

4 mins read
Bio Spectrum
April 2021

Building On Biologics Business Growth

In 1990’s when Hasmukh K Chudgar, founder of Intas Pharmaceuticals handed over the company to his sons Binish, Nimish and Urmish, the company’s turnover was less than $1 million.

2 mins read
Bio Spectrum
April 2021

King Of Vaccines Protecting Children From Birth Onwards

Son of a horse breeder, Cyrus Poonawalla founded Serum Institute of India (SII) in 1966 in Pune when he was just 22 years and got married to Villoo. Over the years, his passion of offering affordable vaccines to the world has motivated to build SII into one of the world’s largest vaccine makers.

2 mins read
Bio Spectrum
April 2021

“We support scientists in all regions researching and developing vaccines against COVID”

Eva van Pelt, Co-CEO & Chief Commercial Officer, Eppendorf AG, Hamburg, Germany

5 mins read
Bio Spectrum
March 2021

NECHRI, IIT-G ink MoU for cancer research

Indian Institute of Technology, Guwahati (IIT-G), has signed a Memorandum of Understanding (MoU) with North East Cancer Hospital and Research Institute (NECHRI), Jorabat, Assam.

1 min read
Bio Spectrum
March 2021

“Peptide purification market is underserved by traditional resin suppliers”

« Jonathan Royce, Chief Executive Officer, Bio-Works Technologies AB, Sweden

5 mins read
Bio Spectrum
March 2021

India rolls out vaccines to neighbouring coThe government has opened a new institute of Council of Scientific and Industrial Research (CSIR) i.e. CSIR-National Institute of Science Communication and Policy Research (CSIR-NIScPR), in New Delhi.untries

The Government of India has received several requests for the supply of Indian manufactured vaccines from neighbouring and key partner countries.

1 min read
Bio Spectrum
March 2021

LEADING FROM THE FRONT

The International Women’s Day theme for 2021, celebrated on March 8 every year, is #ChooseToChallenge, which highlights the importance of challenging biases and misconceptions in the interest of creating a more inclusive and gender-equal world.

10+ mins read
Bio Spectrum
March 2021

CEPI Call provides up to $140M to vaccine developers

Norway based Coalition for Epidemic Preparedness Innovations (CEPI) has opened a new funding opportunity to support the rapid generation of additional clinical research on COVID-19 vaccines.

1 min read
Bio Spectrum
March 2021